In this episode of ‘What’s New Doc’ in GU cancer, Prof Emmanuel Seront...
How does the NEMIO trial improve neoadjuvant chemotherapy in the perioperative...
The widely recognized enfortumab vedotin (EV), which targets nectin-4, was...
In this episode of WND, Prof Emmanuel Seront from UCL Louvain and Prof Vulsteke...
Prof Emmanuel Seront from UCL Louvain and Prof Vulsteke from Maria Middelares...
Dr Marco Gizzi, a medical oncologist at the Grand Hôpital de Charleroi and the...
Prof Christof Vulsteke, medical oncologist at the Integrated Cancer Center,...
Prof Vulsteke from Maria Middelares Gent will present the CheckMate901 study,...
Professor Vulsteke from Maria Middelares Gent will discuss the SunRISE-1 study,...
Professor Vulsteke is a principal investigator in the EV-302 trial, one of the...